chloroquine

Indications retained by WHO

Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax; Malaria due to Plasmodium ovale; Malaria due to Plasmodium malariae; Rheumatoid arthritis.

Listed forms and strengths

• Parenteral > General injections > IV: 40 mg per mL in 5 mL ampoule (as hydrochloride, phosphate or sulfate)
• Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate)
• Oral > Solid: 100 mg tablet (as phosphate or sulfate); 150 mg tablet (as phosphate or sulfate)
• Oral > Liquid: 50 mg per 5 mL (base)
• Oral > Solid > tablet: 150 mg (base)
• Oral > Solid: 150 mg tablet (as phosphate or sulfate)

Forms retained in the model list; presentations available in each country may differ.